It is crucial to mention that plasma levels of LAT1 substrate amino acids are significantly changed in cancer patients: plasma LAT1 substrates were found increased in lung [110,111], prostate [112], and breast cancer patients [113,114]. Here, SLC7A5 is linked to breast carcinoma.